Immunyx selected as a BlueKnight Company

Immunyx Pharma, a developer of immune modulating therapies for neutrophil based diseases, announced it has been selected...

Targeted nanoparticles modify neutrophil function in vivo

Neutrophils play critical roles in a broad spectrum of clinical conditions. Accordingly, manipulation of neutrophil...

Hero image immunyX

Contact Us

Immunyx strives to improve disease treatment. If you’re interested in our mission we would love to hear from you.